메뉴 건너뛰기




Volumn 52, Issue 9, 2002, Pages 654-663

Synthesis and β1-, β2-adrenergic receptor binding studies of 4-acylamino-substituted phenoxypropanolamine and 5-acylamino-substituted naphthyloxypropanolamine derivatives

Author keywords

Aryloxypropanolamines, 1 and 2 adrenergic receptor binding affinity; CAS 318 98 9; Dihydroalprenolol, radiolabelled; Propranolol; Adrenergic blocking agents

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; N [5 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY)NAPHTHALEN 1 YL]ACETAMIDE; NAPHTHYLOXYPROPANOLAMINE DERIVATIVE; PHENOXYPROPANOLAMINE DERIVATIVE; PROPANOLAMINE DERIVATIVE; PROPRANOLOL; UNCLASSIFIED DRUG;

EID: 0036380852     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1299947     Document Type: Article
Times cited : (17)

References (19)
  • 1
    • 0028354464 scopus 로고
    • Antihypertensive drugs: Issues beyond blood pressure control
    • Pinkney, J. H., Yudkin, J. S., Antihypertensive drugs: issues beyond blood pressure control. Prog. Cardiovasc. Dis. 36, 397 (1994)
    • (1994) Prog. Cardiovasc. Dis. , vol.36 , pp. 397
    • Pinkney, J.H.1    Yudkin, J.S.2
  • 2
    • 0034080804 scopus 로고    scopus 로고
    • Receptors in cardiovascular disease: Review and introduction
    • Leonardi, A., Sironi, G., Motta, G., Receptors in cardiovascular disease: review and introduction. Pharm. Acta Helv. 74, 157 (2000)
    • (2000) Pharm. Acta Helv. , vol.74 , pp. 157
    • Leonardi, A.1    Sironi, G.2    Motta, G.3
  • 3
    • 0029943358 scopus 로고    scopus 로고
    • Current drug treatment and treatment patterns with antihypertensive drugs
    • Fries, E. D., Papademetriou, V., Current drug treatment and treatment patterns with antihypertensive drugs. Drugs 52, 1 (1996)
    • (1996) Drugs , vol.52 , pp. 1
    • Fries, E.D.1    Papademetriou, V.2
  • 4
    • 0030713021 scopus 로고    scopus 로고
    • The sixth report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure
    • The sixth report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure, Arch. Intern. Med. 157, 2413 (1997)
    • (1997) Arch. Intern. Med. , vol.157 , pp. 2413
  • 6
    • 0033514046 scopus 로고    scopus 로고
    • The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): A randomized trial
    • CIBIS II investigators and committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomized trial. Lancet 353, 9 (1999)
    • (1999) Lancet , vol.353 , pp. 9
  • 7
    • 0033549290 scopus 로고    scopus 로고
    • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial In Congestive Heart Failure (MERIT-HF)
    • MERIT-HF study group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial In Congestive Heart Failure (MERIT-HF). Lancet 353, 2001 (1999)
    • (1999) Lancet , vol.353 , pp. 2001
  • 8
    • 0034620523 scopus 로고    scopus 로고
    • β-Adrenergic receptor blockade in chronic heart failure
    • Bristow, M. R., β-Adrenergic receptor blockade in chronic heart failure. Circulation 101, 558 (2000)
    • (2000) Circulation , vol.101 , pp. 558
    • Bristow, M.R.1
  • 9
    • 0016433946 scopus 로고
    • Cardioselective β-adrenergic blocking agents. 1. 1[(3,4-Dimethoxyphenethyl)amino]-3-aryloxy-2-propanols
    • Hoefle, M. L., Hastings, S. G., Meyer, R. F. et.al., Cardioselective β-adrenergic blocking agents. 1. 1[(3,4-Dimethoxyphenethyl)amino]-3-aryloxy-2-propanols. J. Med. Chem. 18, 148 (1975)
    • (1975) J. Med. Chem. , vol.18 , pp. 148
    • Hoefle, M.L.1    Hastings, S.G.2    Meyer, R.F.3
  • 10
    • 0022236094 scopus 로고
    • Recent advances in β-adrenergic blocking agents
    • G. P. Ellis, G. B. West (eds.). Elsevier Science Publishers, Amsterdam
    • Main, B. G., Tucker, H., Recent advances in β-adrenergic blocking agents. In: Progress in Medicinal Chemistry, G. P. Ellis, G. B. West (eds.), vol. 22, pp. 121-164. Elsevier Science Publishers, Amsterdam (1985)
    • (1985) Progress in Medicinal Chemistry , vol.22 , pp. 121-164
    • Main, B.G.1    Tucker, H.2
  • 11
    • 0015079957 scopus 로고
    • β-Adrenergic blocking agents. 10. (3-Amino-2-hydroxypropoxy)anilides
    • Crowther, A. F., Howe, R., Smith, L. H., β-Adrenergic blocking agents. 10. (3-Amino-2-hydroxypropoxy)anilides. J. Med. Chem. 14, 511 (1971)
    • (1971) J. Med. Chem. , vol.14 , pp. 511
    • Crowther, A.F.1    Howe, R.2    Smith, L.H.3
  • 12
    • 0032795391 scopus 로고    scopus 로고
    • δ-Adrenergic blocking agents in bronchospastic diseases: A therapeutic dilemma
    • Tafreshi, M. J., Weinacker, A. B., δ-Adrenergic blocking agents in bronchospastic diseases: A therapeutic dilemma. Pharmacotheraphy 19, 974 (1999)
    • (1999) Pharmacotheraphy , vol.19 , pp. 974
    • Tafreshi, M.J.1    Weinacker, A.B.2
  • 15
    • 84969001783 scopus 로고
    • The attractions of proteins for small molecules and ions
    • Scatchard, G., The attractions of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51, 660 (1949)
    • (1949) Ann. N.Y. Acad. Sci. , vol.51 , pp. 660
    • Scatchard, G.1
  • 16
    • 0018745732 scopus 로고
    • The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro
    • Minneman, K. P., Hegstrand, L. R., Molinoff, P. B., The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro. Mol. Pharmacol. 16, 21 (1979)
    • (1979) Mol. Pharmacol. , vol.16 , pp. 21
    • Minneman, K.P.1    Hegstrand, L.R.2    Molinoff, P.B.3
  • 17
    • 0020070721 scopus 로고
    • Changes in the density of beta adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol
    • Aarons, R. D., Molinoff, P. B., Changes in the density of beta adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol. J. Pharmacol. Exp. Ther. 221, 439 (1982)
    • (1982) J. Pharmacol. Exp. Ther. , vol.221 , pp. 439
    • Aarons, R.D.1    Molinoff, P.B.2
  • 18
    • 0017684798 scopus 로고
    • β-Adrenergic blocking agents. 15. 1-Substituted ureidophenoxy-3-amino-2-propanols
    • Smith, L. H., β-Adrenergic blocking agents. 15. 1-Substituted ureidophenoxy-3-amino-2-propanols. J. Med. Chem. 20, 705 (1977)
    • (1977) J. Med. Chem. , vol.20 , pp. 705
    • Smith, L.H.1
  • 19
    • 0019203954 scopus 로고
    • β-Adrenergic blocking agents. 20. (3-Hydroxyprop-1-enyl)-substituted 1-(aryloxy)-3-(alkylamino) propan-2-ols
    • Tucker, H., β-Adrenergic blocking agents. 20. (3-Hydroxyprop-1-enyl)-substituted 1-(aryloxy)-3-(alkylamino) propan-2-ols. J. Med. Chem. 23, 1122 (1980)
    • (1980) J. Med. Chem. , vol.23 , pp. 1122
    • Tucker, H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.